Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Cancer Research|January 10, 2018
Phloridzin docosahexaenoate, a novel flavonoid derivative, suppresses growth and induces apoptosis in T-cell acute lymphoblastic leukemia cellsNiroshaathevi Arumuggam, Nicole Melong, Catherine Kl Too, et al.
Scientific Reports|November 2, 2017
Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardiaNicole Melong, Shelby Steele, Morgan MacDonald, et al.
Elife|July 29, 2020
The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish modelJaime N Wertman, Nicole Melong, Matthew R Stoyek, et al.
Scientific Reports|January 29, 2022
Radiation dose enhancement using gold nanoparticles with a diamond linear accelerator target: a multiple cell type analysisOlivia Piccolo, John D Lincoln, Nicole Melong, et al.
Haematologica|October 15, 2020
Humanized zebrafish enhance human hematopoietic stem cell survival and promote acute myeloid leukemia clonal diversityVinothkumar Rajan, Nicole Melong, Wing Hing Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2017
<i>In Vivo</i> Validation of PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic TargetAda W Y Leung, Chansey J Veinotte, Nicole Melong, et al.
Viruses|December 22, 2019
The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated DiseasesEric S Pringle, Jaime Wertman, Nicole Melong, et al.
Cancer Research Communications|July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision TherapyNadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 3, 2023
Tissue-Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC InhibitionAdam Pietrobon, Julien Yockell-Lelièvre, Nicole Melong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing SarcomaSarah Wang, Elizabeth E Hwang, Rajarshi Guha, et al.
Pageof 2